Benzinga | Nov 3, 2021 09:16AM EDT

Wells Fargo Maintains Equal-Weight on Exact Sciences, Lowers Price Target to $95

Wells Fargo analyst Dan Leonard maintains Exact Sciences (NASDAQ:EXAS) with a Equal-Weight and lowers the price target from $120 to $95.